Integrin Alpha-6 in Prostate Cancer Cell Dissemination: Genetic and Pharmacological Validation in Humanized Zebrafish Xenografts
Cancers · 17.11.2026 · 18 (22) · 3677
DOI: 10.3390/cancers18223677 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancers, online erschienen am 17.11.2026. Verfasst von Ashley Williams und 6 weiteren Autor:innen. Die Arbeit nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: American Cancer Society, U.S. Department of Education Research and Development Infrastructure.
Abstract (Originalsprache)
Background
Dissemination makes prostate cancer lethal, and few therapies target it directly. Integrin alpha-6 (ITGA6) is a laminin-binding receptor cleaved by urokinase (uPA), which releases its extracellular domain and leaves a membrane-retained fragment, α6p. We hypothesized that ITGA6 and its cleavage are required for dissemination in tumor cells and host tissue.
Methods
ITGA6 was knocked down and overexpressed in PC3 cells, and migration and morphology were measured in vitro. Proteins were assessed using immunostaining in PC3 and MDA-MB-231 cells (expression analysis only). Zebrafish xenografts tested loss and gain of function on angiogenesis and dissemination (ten or more labeled cells from the injection site). Cucurbitacin B (CuB), a pleiotropic compound reported to lower ITGA6, was tested to determine whether lowering ITGA6 lessens dissemination. Outcomes were reanalyzed with Fisher’s exact test, as were expression and outcome in TCGA cohorts (4273 tumors, nine types).
Results
Knockdown reduced migration and dissemination in vivo. The host-supplied released extracellular domain displayed the strongest angiogenesis and dissemination, and a non-cleavable mutant reduced dissemination. CuB lowered ITGA6 protein levels and reduced dissemination. ITGA6 was expressed in all nine types, but bulk mRNA was not prognostic in the prostate or breast cohorts.
Conclusions
In the PC3 model, ITGA6 and its cleavage regulate dissemination and angiogenesis in vivo. Blocking cleavage, most directly by antagonizing uPA, is a candidate strategy for testing in further models. Because CuB also acts on other pathways, its effects are consistent with, but do not prove, an ITGA6-mediated mechanism.
Förderung
- American Cancer Society
- U.S. Department of Education Research and Development Infrastructure
Zitieren
APA
Williams, A., Srikumar, S., Khan, Z., Griffis, A., Clark, C., Zehr, L., & Sittaramane, V. (2026). Integrin Alpha-6 in Prostate Cancer Cell Dissemination: Genetic and Pharmacological Validation in Humanized Zebrafish Xenografts. Cancers, 18(22), 3677. https://doi.org/10.3390/cancers18223677
Vancouver
Williams A, Srikumar S, Khan Z, Griffis A, Clark C, Zehr L, et al. Integrin Alpha-6 in Prostate Cancer Cell Dissemination: Genetic and Pharmacological Validation in Humanized Zebrafish Xenografts. Cancers. 2026;18(22):3677. doi:10.3390/cancers18223677
BibTeX
@article{Williams2026,
author = {Williams, Ashley and Srikumar, Siddarth and Khan, Zakir and Griffis, Alexandra and Clark, Chase and Zehr, Louis and Sittaramane, Vinoth},
title = {Integrin Alpha-6 in Prostate Cancer Cell Dissemination: Genetic and Pharmacological Validation in Humanized Zebrafish Xenografts},
journal = {Cancers},
year = {2026},
volume = {18},
number = {22},
pages = {3677},
doi = {10.3390/cancers18223677}
}
EUVIMED